Summary
The effects of 6-hydroxydopamine (6-OHDA) lesions on brain adrenergic receptor adaptation to 21 days of treatment with the selective monoamine oxidase type A (MAO-A) inhibitor clorgyline were studied in rats. 6-OHDA pretreatment effectively blocked the decrease in α1-, α2- and β-adrenergic receptor densities observed in response to clorgyline treatment. In saline-treated rats, 6-OHDA reduced norepinephrine (NE) to 8% of control levels, modestly reduced dopamine (DA) to 67% of controls, but did not affect serotonin (5HT) levels in the cortex, Clorgyline administration to shams increased NE and 5HT to 239% and 160% of their respective control levels, but did not effect DA levels. 6-OHDA lesions attenuated clorgyline's effect on cortical NE levels but not 5HT. The results suggest that β-adrenergic receptor adaptation to MAOI's as with tricyclic antidepressants is a response to an increase in catecholamine receptor occupancy, and that a similar molecular mechanism is responsible for the observed clorgyline induced changes in α-adrenergic receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aulakh CS, Cohen RM, McLellan C, Murphy DL (1983) Correlations of changes in α-2-adrenoreceptor number and locomotor responses to clonidine following clorgyline discontinuation. Br J Pharmacol 80:10–12
Breese GR, Cooper BR (1977) Chemical lesioning: Catecholamine pathways in methods in psychobiology, Meyers R (ed) Academic Press, New York, pp 27–46
Charney DC, Menkes DB, Heninger GR (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment: Implications for the etiology and therapy of depression. Arch Gen Psychiatry 38:1160–1180
Chiueh CC, Zukowska-Grojec Z, Kirk KL, Kopin IJ (1983) 6-Fluorocatecholamines as false adrenergic neurotransmitters. J Pharmacol Exp Ther 225:529–533
Cohen RM, Aulakh CS, Campbell IC, Murphy DL (1982a) Functional subsensitivity of α2 accompanies reductions in yohimbine binding after clorgyline treatment. Eur J Pharmacol 81:145–148
Cohen RM, Campbell IC, Cohen MR, Torda R, Pickar D, Siever LJ, Murphy DL (1980) Presynaptic noradrenergic regulation during depression and antidepressant drug treatment. Psychiatry Res 3:93–105
Cohen RM, Campbell IC, Dauphin M, Tallman JF, Murphy DL (1982c) Changes in α-and β-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants. Neuropharmacology 21:293–298
Cohen RM, Ebstein RP, Daly JW, Murphy DL (1982b) Chronic effects of a monoamine-oxidase inhibiting antidepressant: Decrease in functional alpha-adrenergic autoreceptors precede the decrease in norepinephrine stimulated cyclic AMP systems in rat brain. J Neurosci 2:1588–1595
Crews FT, Smith CB (1978) Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science 202:322–324
Crews FT, Smith CB (1981) Acceleration of beta-receptor desensitization in combined administration of antidepressants and phenoxybenzamine. Nature 290:787–789
Dibner MD, Molinoff PB (1979) Agonist induced change in betaadrenergic receptor density and receptor modified responsiveness in slices of rat cerebral cortex. J Pharmacol Exp Ther 210:433–439
Janowsky A, Steranka LR, Gillespie DD, Sulser F (1982) Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs. J Neurochem 39:290–292
Knoll B, Held G, Gyarmati Z (1977) The effect of selective MAO inhibitors on the conditioned avoidance response of Wistar rats. Pol J Pharmacol Pharm 29:291–296
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Maggi A, U'Prichard DC, Enna SJ (1980) β-Adrenergic regulation of α2-adrenergic receptors in the central nervous system. Science 207:645–646
Munson PJ, Rodbard D (1980) Ligand: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239
Reisine T (1981) Adaptive changes in catecholamine receptors in the central nervous system. Neuroscience 6:1471–1502
Reisine TD, U'Prichard DC, Wiech NL, Ursillo RC, Yamamura HI (1980) Effects of combined administration of amphetamine and iprindole on brain adrenergic receptors. Brain Res 188:587–592
Schoffelmeer A, Mulder AH (1982) 3H-noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha adrenergic modulation after long-term desipramine pretreatment. Naunyn-Schmiedeberg's Arch Pharmacol 318: 173–180
Schweitzer JW, Schwartz R, Friedhoff AJ (1979) Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine. J Neurochem 33:377–379
Skolnick P, Stolvey LP, Daly JW, Hogler E, Davis JN (1978) Binding of α- and β-adrenergic ligands to cerebral cortical membranes: Effect of 6-hydroxydopamine treatment and relationship to the responsiveness of cyclic AMP-generating systems in two rat strains. Eur J Pharmacol 47:201–210
Sulser F, Vetulani J, Mobley P (1978) Mode of action of antidepressant drugs. Biochem Pharmacol 27:257–261
Svensson T, Usdin T (1978) Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha receptor mediation. Science 202:1089–1091
U'Prichard D, Bechtel W, Rouot B, Snyder SH (1979) Multiple apparent alpha noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol Pharmacol 16:47–60
Valley L, Cardo B, Bockaert J (1981) Modulation of rat brain α-adrenoceptor populations four weeks after stimulation of the nucleus locus coeruleus. Psychopharmacology 74:226–231
Waldmeier PC, Belner AE, Maitre L (1981) Long-term effects of selective MAO inhibitors on MAO activity and amine metabolism. In: Youdim M, Paykel E (eds) Monoamine oxidase inhibitors. The state of the art. Wiley, Chichester, pp 87–102
Winer BT (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
Wolfe BB, Harden TK, Sporn JR, Molinoff PB (1978) Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther 207:446–457
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen, R.M., Aulakh, C., McLellan, C. et al. 6-Hydroxydopamine pretreatment effects on α- and β-adrenergic receptor adaptation to clorgyline. Naunyn-Schmiedeberg's Arch. Pharmacol. 329, 158–161 (1985). https://doi.org/10.1007/BF00501206
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501206